Curcumin loaded electrospun poly (2-hydroxyethyl methacrylate) p(HEMA) nanofibers as Antioxidant and Anticancer agents

Authors

  • Nithya Ramalingam .
  • Sheeja Rajiv Department of Chemistry, Anna University, Chennai-25.

Keywords:

CDKN2A, Curcumin, DPPH, ABTS, p(HEMA) nanofiber

Abstract

Curcumin loaded poly(2-hydroxyethyl metharcylate) p(HEMA) nanofiber were prepared using electrospinning technique. The curcumin loaded nanofiber induced dose and time based cell proliferation on A375 melanoma cells. Good free radical scavenging activity were exhibited by DPPH and ABTS methods. Apoptotic activity at 200µg concentration at 192 hrs was effective by DAPI staining method. Expression of cyclin dependent kinase (CDKN2A) gene was quantified by real time quantitative PCR and mRNA expression was up regulated. Hence the results shows that curcumin loaded p(HEMA) nanofiber exihibit good anticancer and antioxidant property

References

1. Julie M.L, Michael S, Jenny C, Njauw N, Luo S, Julia NB, Mark H, Nicholas KH, Margaret AT, Alisa MG, Maria TL, Surana P, Nelleke AG, Wilma B, Giovanna BS, Paola G, David H, Hensin T. A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindereds. Journal of Investigative Dermatology. 2011;131: 480-486.
2. Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-e Paillerets, B, Azizi E. Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumuors. British Journal of Cancer. 2005; 92: 2278-2285.
3. Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK. CDKN2A/p16 is Inactivated in Most Melanoma Cell Lines. Cancer Research. 1997; 57: 4868-4875.
4. Lang L, Boxer M, Mackie RM. CDKN2A Mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families. British Journal of Dermatology 2005;153: 1121-1125.
5. Nithya R, Natarajan T S, Sheeja R. Preparation and characterization of electrospun curcumin loaded poly (2-hydroxyethyl methacrylate) nanofibers- biomaterial for multidrug resistant organisms. Journal of Biomedical Materials Research part A. 2014; 103(1):16-24.
6. Su CC, Wang MJ , Chiu TL. The anticancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. International Journal of Molecular Medicine 2010; 26: 217-224.
7. Liu TY, Tan JH, Jiang L, Gu JF, Wu XS, Cau Y, Li ML, Wu KJ, Liu YB. Curcumin induces apopotosis in gall baldder carcinoma cell line GBC –SD cells. Cancer Cell International 2013;13: 64.
8. Kulygin O, Silverstein MS. Porous Poly(2-hydroxyethyl methacrylate) hydrogels synthesized within high internal phase emulsions. Soft Matter 2007; 3: 15251529. 9. Tomic SLJ, Micie MM, Filiparic JM, Suljovrujic EH. Synthesis, characterization and controlled release of cephalexin drug from smart poly(2-hydroxyethyl methacrylate) poly(alkylene glycol) methacrylate hydrogels. Chemical Engineering Journal 2010;160: 801-809.
10. Nithya R, Natarajan TS, Sheeja R. Development and Characterization of Electrospun poly(2-hydroxyethyl methacrylate) for Tissue engineering Applications, Advances in Polymer Technology. 2013; 32 (3):2134821355.
11. Trinh P, Atzed S, Curtin S, Ratner B. Characterisation of poly(2-hydroxyethyl- methacrylate) scaffolds. Journal of Undergraduate Research in Bioengineering 20082010; 8: 98-104.
12. Anderson EM, Noble ML, Ma H, Bryers JD, Shan TT, Ratner BD. Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery. Biomaterials 2009; 30: 5675-5681.
13. Sowmya S, Sankar Ganesh J, Rajiv S. Biodegradable electrospun nanocomposite fiber based on poly(2hydroxyethyl methacrylate) and bamboo cellulose. Composite B 2014; 60: 43-48.
14. Kulkarni A, Bambole VA, Mahanwar PA. Electrospinning of polymers, Their modeling and Applications. Polymer- Plastics Technology and Engineering 2010; 49: 427-441.
15. Bibekanda S, Subramanian V, Natarajan TS, Krishna murthy K. Electrical conductivity of single electrospun fiber of poly(methyl methacrylate) and multiwalled carbon nanotube nanocomposites. Applied Physics Letter 2006; 8: 14.
16. Dolatabadi JEN, Makhtarzadeh A, Ghareghoran SM, Dehghan G. Synthesis, Characterisation and Antioxidant property of Quercetin Tb(III) complex. Advanced Pharmaceutical Bulletin 2014; 4 (2):101-104.
17. Sandra F, Matsuda M, Yoshida H, Hirata M. Inositol hexakinase phosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. Carcinogenesis 2002; 23: 2031-2041.
18. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with progression of Adult T-cell Leukemia Cancer Research 2000; 60: 1043-1048. 19. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptman S, Schnorr D, Loening SA, Lichtinghagen R. Differential Expression of Matrix Metalloproteinases and their Tissue Inhibition in Human Primary Cultured Prostatic cells and Malignant Prostrate cell lines. The Prostrate 2002, 50: 38-45.
20. Livak KJ and Schimittgen TD. Analysis of Relative Gene Expression Data Using Real Time Quantative PCR and the 2-??ct method. Methods, 2001, 25: 405-408. 21. Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Carbohydrate Polymers, 2011, 83: 452-461.
22. Tuba AK and Gulcin I. Antioxidant and radical Scanvenging properties of curcumin. ChemicoBiological Interactions 2008, 174: 27-37.
23. Loo CY, Arya A, Cheah FK, Muharram B, Leong KH, Mohammad K, Wong WF, Rai N, Mustafa MS. Induction of apoptosis in human Breast cancer cells via caspase pathway by Vernadalin isolated from Centratherum anthelminticum (L) seeds. PLOS ONE, 2013, 8: 1-20.
24. Ogbah Z, Butille, JAP, Simonnetta F, Badenas C, Cervera R, Mila J, Bentez D, Malvehy J, Vilela R, Puig S. Molecular Characterisation of Human Cutaneous Melanoma derived cell lines. Anticancer Research 2012, 32: 1245-1252.

Published

2019-05-17

Issue

Vol. 1 No. 1 (2019): Journal of Advanced Research in Nanoscience and Nanotechnology

Section

Research Article

Copyright (c) 2018 Journal of Advanced Research in NanoScience and NanoTechnology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.